Loading insider details...
Beta
Latest Form 4 (Jun 25, 2026): Grant/Award of 28,000 FHTX shares, $114.2K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 25, 2026 | Foghorn Therapeutics Inc. (FHTX) | Grant/Award | 28,000 | $114.2K |
| Jun 12, 2026 | Milestone Pharmaceuticals Inc. (MIST) | Grant/Award | 77,000 | n/a |
| Jan 6, 2026 | EyePoint, Inc. (EYPT) | Grant/Award | 40,000 | n/a |
| Jun 12, 2025 | Milestone Pharmaceuticals Inc. (MIST) | Grant/Award | 40,000 | n/a |
| Jun 10, 2025 | ACHIEVE LIFE SCIENCES, INC. (ACHV) | Grant/Award | 31,500 | n/a |
| May 2, 2025 | Foghorn Therapeutics Inc. (FHTX) | Grant/Award | 50,000 | $208.0K |
| Jan 7, 2025 | EyePoint Pharmaceuticals, Inc. (EYPT) | Grant/Award | 40,000 | n/a |
| Aug 29, 2024 | Milestone Pharmaceuticals Inc. (MIST) | Grant/Award | 40,000 | n/a |
| Jul 17, 2024 | Milestone Pharmaceuticals Inc. (MIST) | Grant/Award | 80,000 | n/a |
| Jan 25, 2024 | ACHIEVE LIFE SCIENCES, INC. (ACHV) | Grant/Award | 31,500 | n/a |